查看购物车
  • Traditional Chinese
  • English
2021-2031年亚太地区栓塞器材市场报告：范围、细分、动态与竞争分析
市场调查报告书
商品编码
1871491

2021-2031年亚太地区栓塞器材市场报告：范围、细分、动态与竞争分析

Asia Pacific Embolization Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 188 Pages | 订单完成后即时交付

价格

预计亚太地区栓塞器械市场将显着成长，到 2031 年将达到约 13.0234 亿美元，高于 2024 年的 6.591 亿美元，2025 年至 2031 年的年复合成长率(CAGR) 预计为 10.3%。

执行摘要和市场分析

市场分为多个区域，包括中国、日本、印度、韩国、澳洲以及亚太其他地区。推动市场成长的关键因素是癌症和其他疾病发生率的上升，这增加了对栓塞等介入治疗的需求。此外，技术的进步显着提高了栓塞装置的疗效和安全性，包括药物洗脱微球、微导管和新型弹簧圈设计等创新技术。这些改进不仅改善了临床疗效，还缩短了手术时间，减少了术后併发症，使这些手术对医护人员和患者更具吸引力。

微创手术技术的普及是推动市场成长的另一个关键因素。与传统手术相比，微创手术具有许多优势，包括住院时间更短、恢復更快、併发症风险更低。随着医护人员和病患对这些优势的认识不断提高，预计栓塞手术的需求将会增加。

市场区隔分析

亚太地区栓塞器械市场可按类型、应用和最终用户进行细分。

  • 依类型划分：市场产品包括栓塞线圈、栓塞塞、栓塞珠、栓塞胶等。 2024年，栓塞线圈占据最大的市场份额，并进一步细分为中心栓塞和周边栓塞。
  • 按应用领域划分：市场分为神经病学、週边血管疾病、肿瘤学、泌尿学和其他领域，其中神经病学在 2024 年将成为领先领域。
  • 按最终用户划分：最终用户主要是医院、门诊中心等，预计到 2024 年，医院将占据市场份额的主导地位。

市场展望

栓塞术是一种微创技术，它透过导管输送栓塞剂，阻断特定区域（例如肿瘤或异常血管）的血流。此方法广泛用于治疗动静脉畸形（AVM）、动脉瘤和某些癌症。由于其相较于传统手术方法具有许多优势，例如住院时间更短、併发症发生率更低、恢復更快，因此栓塞术越来越受到青睐。

例如，子宫动脉栓塞术是治疗子宫肌瘤的有效替代方法，其成功率超过90%，同时仍保留子宫功能，这对育龄妇女尤其重要。此外，老年合併多种疾病的患者通常更倾向于微创治疗。经动脉化疗栓塞术（TACE）已成为肝细胞癌（HCC）的第一线标准治疗方法，HCC是老年人常见的肝癌。 TACE中使用微球和载药微球不仅可以阻断血液供应，还能局部递送化疗药物，从而提高治疗效果并最大限度地减少全身副作用。据美国国家癌症研究所称，TACE可将中期HCC患者的中位存活期延长至20个月，为手术切除提供了更安全的替代方案。

生物可吸收栓塞材料的出现是市场上的另一个重大进展，它能提供暂时性的血管阻塞，并被人体逐渐吸收，从而减少长期併发症，并为未来的治疗提供更多选择。随着医疗系统越来越倾向于微创和经济有效的介入治疗，患者和临床医生都优先考虑那些能够最大限度减少创伤、缩短恢復时间和降低併发症的治疗方案。因此，栓塞术正逐渐成为传统手术的更佳替代方案，为患者提供标靶治疗、缓解症状并改善生活品质。

国家概况

亚太地区栓塞器械市场涵盖中国、日本、印度、澳洲、韩国等主要国家，预计2024年，中国将占最大的市场份额。中国面临严重的周边动脉疾病（PAD）负担，据报道，2000年至2020年间，PAD病例增加了40%。中国是亚太地区第二型糖尿病患者人数最多的国家，而糖尿病是PAD的主要危险因子。在中国，糖尿病患者的PAD盛行率在6%至10%之间。

技术进步对市场成长至关重要，例如微创医疗等公司正引领着针对本地需求的栓塞器材的研发。收购和产品创新等策略措施在市场参与者中十分普遍。例如，格兰德药业收购了神明医疗科技，以增强其肿瘤介入产品线；而Zylox-Tonbridge的栓塞系统则于2024年初获得批准。

公司简介

栓塞器械市场的主要参与者包括美敦力、库克医疗、史赛克、波士顿科学、泰尔茂、强生、雅培等。这些公司正致力于扩张、产品创新以及併购，以增强市场份额并为消费者提供创新解决方案。

目录

第一章：引言

第二章：执行概要

  • 关键见解

第三章：研究方法

  • 二手研究
  • 初步研究
    • 假设的提出：
    • 宏观经济因素分析：
    • 发展基数：
    • 数据三角测量：
    • 国家层面资料：
  • 假设和局限性

第四章：亚太地区栓塞器材市场－主要市场动态

  • 亚太地区栓塞器材市场－主要市场动态
  • 市场驱动因素
    • 临床疾病盛行率上升
    • 对微创技术的需求日益增长
  • 市场限制
    • 栓塞术期间或之后出现的併发症
  • 市场机会
    • 新产品开发及市场推广审批
  • 未来趋势
    • 透过临床创新变革栓塞治疗
  • 驾驶员和安全带的影响：

第五章：栓塞器械市场－亚太地区分析

  • 2021-2031年亚太地区栓塞器材市场收入
  • 亚太地区栓塞器材市场预测分析

第六章：亚太地区栓塞器材市场分析－依产品类型划分

  • 栓塞线圈
  • 插头
  • 珠
  • 胶水
  • 其他的

第七章：亚太地区栓塞器材市场分析－依应用领域划分

  • 神经病学
  • 週边血管疾病
  • 肿瘤学
  • 泌尿科
  • 其他的

第八章：亚太地区栓塞器材市场分析－依最终使用者划分

  • 医院
  • 门诊中心
  • 其他的

第九章：亚太地区栓塞器材市场—国别分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太其他地区

第十章：竞争格局

  • 关键参与者热力图分析
  • 公司定位与集中度

第十一章：行业概况

  • 概述
  • 扩张
  • 新产品开发与审批
  • 併购
  • 伙伴关係与合作

第十二章：公司简介

  • Medtronic Plc
  • Cook Medical Holdings LLC
  • Stryker Corp
  • Boston Scientific Corp
  • Terumo Corp
  • Johnson & Johnson
  • Abbott Laboratories
  • NeuroSafe Medical Co. Ltd
  • Wallaby Medical
  • Sirtex Medical Ltd
  • GEM srl
  • Penumbra Inc.
  • Balt
  • Lepu Medical Technology Beijing Co Ltd
  • INVAMED
  • Meril Life Sciences Pvt Ltd
  • Merit Medical Systems Inc
  • Lifetech Scientific Corp

第十三章：附录

Product Code: BMIRE00032148

The Asia Pacific embolization devices market is projected to grow significantly, reaching approximately US$ 1,302.34 million by 2031, up from US$ 659.10 million in 2024, with an estimated compound annual growth rate (CAGR) of 10.3% from 2025 to 2031.

Executive Summary and Market Analysis

The market is divided into several regions, including China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. A key driver of this market growth is the rising incidence of cancer and other medical conditions, which increases the demand for interventional procedures like embolization. Additionally, advancements in technology have significantly improved the efficacy and safety of embolization devices, including innovations such as drug-eluting beads, microcatheters, and new coil designs. These improvements not only enhance clinical outcomes but also minimize procedure times and reduce post-operative complications, making these procedures more appealing to both healthcare providers and patients.

The trend towards minimally invasive surgical techniques is another crucial factor contributing to market growth. Such procedures offer numerous advantages, including shorter hospital stays, faster recovery, and a lower risk of complications compared to traditional surgeries. As awareness of these benefits grows among healthcare providers and patients, the demand for embolization procedures is expected to increase.

Market Segmentation Analysis

The Asia Pacific embolization devices market can be segmented by type, application, and end user.

  • By Type: The market includes embolization coils, plugs, beads, glues, and others. In 2024, embolization coils held the largest market share, further divided into central and peripheral applications.
  • By Application: The market is categorized into neurology, peripheral vascular disease, oncology, urology, and others, with neurology being the leading segment in 2024.
  • By End User: The end users are primarily hospitals, ambulatory centers, and others, with hospitals dominating the market share in 2024.

Market Outlook

Embolization is a minimally invasive technique that blocks blood flow to specific areas, such as tumors or abnormal blood vessels, using embolic agents delivered via catheters. This method is widely used for treating arteriovenous malformations (AVMs), aneurysms, and certain cancers. The preference for these techniques is increasing due to their advantages over traditional surgical methods, including reduced hospital stays, lower complication rates, and quicker recovery times.

For instance, uterine artery embolization is an effective alternative to hysterectomy for treating uterine fibroids, achieving success rates exceeding 90% while preserving uterine function, which is particularly important for women of reproductive age. Furthermore, older patients with comorbidities often prefer minimally invasive options. Transarterial chemoembolization (TACE) has become a standard first-line treatment for hepatocellular carcinoma (HCC), a prevalent liver cancer among older adults. The use of microspheres and drug-eluting beads in TACE not only blocks blood supply but also delivers localized chemotherapy, enhancing treatment efficacy and minimizing systemic side effects. According to the National Cancer Institute, TACE can extend median survival for intermediate-stage HCC patients to 20 months, providing a safer alternative to surgical resection.

The emergence of bioresorbable embolic materials is another significant development in the market, offering temporary occlusion that the body gradually absorbs, thus reducing long-term complications and allowing for future treatment options. As healthcare systems increasingly favor minimally invasive and cost-effective interventions, both patients and clinicians are prioritizing treatment options that minimize trauma, recovery time, and complications. Consequently, embolization is becoming a preferred alternative to traditional surgeries, providing targeted treatment, symptom relief, and improved quality of life for patients.

Country Insights

The Asia Pacific embolization devices market includes key countries such as China, Japan, India, Australia, South Korea, and others, with China holding the largest market share in 2024. China faces a significant burden of peripheral artery disease (PAD), with a reported 40% increase in cases from 2000 to 2020. The country has the highest number of type 2 diabetes patients in the region, which is a major risk factor for PAD. The prevalence of PAD among diabetic patients in China ranges from 6% to 10%.

Technological advancements are crucial for market growth, with companies like MicroPort leading the development of embolization devices tailored to local needs. Strategic activities, such as acquisitions and product innovations, are common among market players. For example, Grand Pharmaceutical acquired Shenming Medical Technology to enhance its tumor intervention product pipeline, while Zylox-Tonbridge received approval for its embolization system in early 2024.

Company Profiles

Key players in the embolization devices market include Medtronic, Cook Medical, Stryker, Boston Scientific, Terumo, Johnson & Johnson, Abbott Laboratories, and others. These companies are focusing on expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Asia Pacific Embolization Devices Market - Key Market Dynamics

  • 4.1 Asia Pacific Embolization Devices Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Clinical Conditions
    • 4.2.2 Burgeoning Demand for Minimally Invasive Techniques
  • 4.3 Market Restraints
    • 4.3.1 Complications Arising During or After Embolization
  • 4.4 Market Opportunities
    • 4.4.1 New Product Developments and Marketing Approvals
  • 4.5 Future Trends
    • 4.5.1 Transforming Embolization Through Clinical Innovation
  • 4.6 Impact of Drivers and Restraints:

5. Embolization Devices Market - Asia Pacific Analysis

  • 5.1 Asia Pacific Embolization Devices Market Revenue (US$ Million), 2021-2031
  • 5.2 Asia Pacific Embolization Devices Market Forecast Analysis

6. Asia Pacific Embolization Devices Market Analysis - by Product Type

  • 6.1 Embolization Coils
    • 6.1.1 Overview
    • 6.1.2 Embolization Coils: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Plugs
    • 6.2.1 Overview
    • 6.2.2 Plugs: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Beads
    • 6.3.1 Overview
    • 6.3.2 Beads: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Glues
    • 6.4.1 Overview
    • 6.4.2 Glues: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Others
    • 6.5.1 Overview
    • 6.5.2 Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Asia Pacific Embolization Devices Market Analysis - by Application

  • 7.1 Neurology
    • 7.1.1 Overview
    • 7.1.2 Neurology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Peripheral Vascular Disease
    • 7.2.1 Overview
    • 7.2.2 Peripheral Vascular Disease: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Oncology
    • 7.3.1 Overview
    • 7.3.2 Oncology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Urology
    • 7.4.1 Overview
    • 7.4.2 Urology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Embolization Devices Market Analysis - by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Ambulatory Centers
    • 8.2.1 Overview
    • 8.2.2 Ambulatory Centers: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Embolization Devices Market - Country Analysis

  • 9.1 Asia Pacific
    • 9.1.1 Asia Pacific Embolization Devices Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Asia Pacific Embolization Devices Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.2 China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.2.1 China: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.2.2 China: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.2.3 China: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.2.4 China: Asia Pacific Embolization Devices Market Share - by End User
      • 9.1.1.3 Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.3.1 Japan: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.3.2 Japan: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.3.3 Japan: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.3.4 Japan: Asia Pacific Embolization Devices Market Share - by End User
      • 9.1.1.4 India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.4.1 India: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.4.2 India: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.4.3 India: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.4.4 India: Asia Pacific Embolization Devices Market Share - by End User
      • 9.1.1.5 Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.5.1 Australia: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.5.2 Australia: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.5.3 Australia: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.5.4 Australia: Asia Pacific Embolization Devices Market Share - by End User
      • 9.1.1.6 South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.6.1 South Korea: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.6.2 South Korea: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.6.3 South Korea: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.6.4 South Korea: Asia Pacific Embolization Devices Market Share - by End User
      • 9.1.1.7 Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.7.1 Rest of APAC: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.7.2 Rest of APAC: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.7.3 Rest of APAC: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.7.4 Rest of APAC: Asia Pacific Embolization Devices Market Share - by End User

10. Competitive Landscape

  • 10.1 Heat Map Analysis by Key Players
  • 10.2 Company Positioning and Concentration

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Expansion
  • 11.3 New Product Development and Approval
  • 11.4 Merger and Acquisition
  • 11.5 Partnerships and Collaboration

12. Company Profiles

  • 12.1 Medtronic Plc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Cook Medical Holdings LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Stryker Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Boston Scientific Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Terumo Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Johnson & Johnson
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Abbott Laboratories
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 NeuroSafe Medical Co. Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Wallaby Medical
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Sirtex Medical Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 GEM srl
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Penumbra Inc.
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Balt
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Lepu Medical Technology Beijing Co Ltd
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 INVAMED
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 Meril Life Sciences Pvt Ltd
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 Merit Medical Systems Inc
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments
  • 12.18 Lifetech Scientific Corp
    • 12.18.1 Key Facts
    • 12.18.2 Business Description
    • 12.18.3 Products and Services
    • 12.18.4 Financial Overview
    • 12.18.5 SWOT Analysis
    • 12.18.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Embolization Devices Market Segmentation
  • Table 2. Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product Type
  • Table 4. Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 8. China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 9. China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 10. China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 11. Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 12. Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 13. Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 14. Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 15. India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 16. India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 17. India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 18. India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 19. Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 20. Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 21. Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 22. Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 23. South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 24. South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 25. South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 26. South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 27. Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 28. Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 29. Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 30. Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 31. Glossary of Terms, Embolization Devices Market

List Of Figures

  • Figure 1. Asia Pacific Embolization Devices Market Segmentation - Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Asia Pacific Embolization Devices Market Revenue (US$ Million), 2021-2031
  • Figure 4. Asia Pacific Embolization Devices Market Share (%) - by Product Type (2024 and 2031)
  • Figure 5. Embolization Coils: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 6. Plugs: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Beads: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Glues: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Asia Pacific Embolization Devices Market Share (%) - by Application (2024 and 2031)
  • Figure 11. Neurology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Peripheral Vascular Disease: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Oncology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Urology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Asia Pacific Embolization Devices Market Share (%) - by End User (2024 and 2031)
  • Figure 17. Hospitals: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Ambulatory Centers: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Asia Pacific Embolization Devices Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 21. China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Heat Map Analysis by Key Players
  • Figure 28. Company Positioning and Concentration